Affinity probes based on small-molecule inhibitors for tumor imaging

Area of Science:

• Molecular imaging
• Cancer diagnostics
• Drug development

Background:

• Molecular imaging techniques like optical, radionuclide, and magnetic resonance imaging are crucial for early cancer diagnosis and treatment.
• Small-molecule inhibitors targeting overexpressed proteins in cancer cells are valuable for developing targeted cancer probes.

Purpose of the Study:

• To review structural designs of affinity probes based on small-molecule inhibitors.
• To discuss the impact of structural modifications (inhibitor, linker, dye, radionuclide) on probe affinity and pharmacokinetics.
• To provide insights for future research and clinical translation of these probes.

Main Methods:

• Literature review summarizing structural designs of small-molecule inhibitor affinity probes.
• Analysis of how different structural components influence probe characteristics.
• Presentation of clinical application examples.

Main Results:

• Detailed summary of structural designs for affinity probes, considering inhibitor, linker, dye, and radionuclide.
• Discussion on the effects of structural modifications on probe affinity and pharmacokinetic properties.
• Examples of inhibitor affinity probes in clinical use.

Conclusions:

• Structural modifications of small-molecule inhibitor affinity probes significantly affect their performance in molecular imaging.
• Understanding these structure-activity relationships is key for developing effective probes for cancer diagnosis and treatment.
• This review offers insights for advancing future research and clinical applications of targeted cancer imaging probes.